TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Pathology Testing Services for HFE Genes

Blood analysis services
Pathology services
Wales (UKL)
Published value
£65,000
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Betsi Cadwaladr University Health Board: "Pathology Testing Services for HFE Genes". Published status: complete. Published value: £65,000. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityBetsi Cadwaladr University Health BoardScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)£65,000
Bidder Intelligence · Authority Profile: Betsi Cadwaladr University Health Board
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Betsi Cadwaladr University Health Board. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2Bids / Report
0% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 1 active published awards; 1 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBetsi Cadwaladr University Health Board
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Jul 2026, 16:50 BST
Last source update17 Jul 2026, 16:50 BST
Recurring procurementNot published
ClassificationBlood analysis services, Pathology services
Delivery area
Wales (UKL)
OCIDocds-h6vhtk-06b954
What is being bought
Betsi Cadwaladr University Health Board intends to award a contract to a provider under the Most Suitable Provider Process for the provision of Pathology Testing Services for HFE Genes including extraction
What changed
From the official release history
  1. tender value changed
    17 Jul 2026, 16:50 BST
  2. Status changed to complete
    17 Jul 2026, 16:50 BST
  3. Official notice release published
    17 Jul 2026, 16:50 BST
  4. Published value updated to £65,000
    19 Jun 2026, 14:51 BST
  5. Status changed to planned
    19 Jun 2026, 14:51 BST
  6. Official notice release published
    19 Jun 2026, 14:51 BST
  7. Buyer information updated
    19 Jun 2026, 14:51 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    This is a Provider Selection Regime (PSR) Intention to Award Notice. Betsi Cadwaladr University Health Board (BCUHB) intends to to award a contract under the Most Suitable Provider Process under The Health Services (Provider Selection Regime) (Wales) Regulations 2025 for the provision of outsourced pathology testing services for HFE genes, including sample extraction. In accordance with the Most Suitable Provider Process, the Contracting Authority has considered which providers are capable of delivering the service and, having regard to the key criteria and all relevant information available at this time, considers that it has identified the most suitable provider to deliver the requirement. The Contracting Authority intends to award a single contract to the most suitable provider. This Intention to Award Notice will be published for a period of at least 8 days. Additional information: This is a Provider Selection Regime (PSR) Intention to Award a Contract Notice. The contract is subject to The Health Services (Provider Selection Regime) (Wales) Regulations 2025 and is intended to be awarded using the Most Suitable Provider Process.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Jul 2026, 16:50 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 17 Jul 2026, 00:00 BST · £47,000
Commercial outcome and competition
Awards
Randox Laboratories Ltd
Not published · Not published · active
Contracts
Contract
£47,000 · signed 17 Jul 2026, 00:00 BST · active
Bid statistics
bids: 2 (lot 1)
electronicBids: 0 (lot 1)
foreignBidsFromEU: 2 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 0 (lot 1)
Buyer and organisations in this procedure

Betsi Cadwaladr University Health Board

Contracting authority GB-FTS-182800
View buyer profile

  • Betsi Cadwaladr University Health Board
    buyer
    centralPurchasingBody

    Headquarters Ysbyty Gwynedd, Penrhosgarnedd, Bangor, UK, LL57 2PW
    nwssp.procurementcataloguepathology@wales.nhs.uk

  • High Court
    reviewBody

    Royal Courts of Justice, The Strand, London, WC2A 2LL
    +44 2079477501

  • Randox Laboratories Ltd
    supplier

    55 Diamond Road,, Crumiln, UK, BT294QY
    +44 2894422413
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published